Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-581-0 | CAS number: 108-42-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Link to relevant study records
- Endpoint:
- two-generation reproductive toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- (Q)SAR
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Justification for type of information:
- QSAR prediction: migrated from IUCLID 5.6
- Principles of method if other than guideline:
- Prediction is done using QSAR Toolbox version 3.1
- GLP compliance:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Type of inhalation exposure (if applicable):
- not specified
- Vehicle:
- not specified
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 2 year
- Control animals:
- not specified
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- not specified
- Food consumption and compound intake (if feeding study):
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Histopathological findings: non-neoplastic:
- not specified
- Other effects:
- not specified
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- not specified
- Dose descriptor:
- NOAEL
- Effect level:
- 127 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No clinical signs of toxicity were reported.
- Remarks on result:
- other: not specified
- Critical effects observed:
- not specified
- Organ:
- not specified
- Clinical signs:
- not specified
- Mortality / viability:
- not specified
- Body weight and weight changes:
- not specified
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- not specified
- Histopathological findings:
- not specified
- Key result
- Dose descriptor:
- dose level:
- Generation:
- other: not specified
- Based on:
- other: not specified
- Sex:
- not specified
- Basis for effect level:
- other: not specified
- Remarks on result:
- other: not specified
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Reproductive effects observed:
- not specified
- Treatment related:
- not specified
- Conclusions:
- The oral administration of 3-chloroaniline to male/female Sprague-Dawley rat ,at a dose level of 127 mg/kg bw/day (actual dose received).No clinical signs of toxicity were reported.
Thus the NOAEL for reproductive toxicity study was considered to be 127 mg/kg bw/day (actual dose received). - Executive summary:
The oral administration of 3-chloroaniline to male/female Sprague-Dawley rat ,at a dose level of 127 mg/kg bw/day (actual dose received).No clinical signs of toxicity were reported.
Thus the NOAEL for reproductive toxicity study was considered to be 127 mg/kg bw/day (actual dose received).
Reference
The
prediction was based on dataset comprised from the following
descriptors: NOAEL
Estimation method: Takes average value from the 5 nearest neighbours
Domain logical expression:Result: In Domain
((("a"
or "b" or "c" or "d" or "e" )
and "f" )
and ("g"
and "h" )
)
Domain
logical expression index: "a"
Referential
boundary: The
target chemical should be classified as Anilines (Acute toxicity) by
US-EPA New Chemical Categories
Domain
logical expression index: "b"
Referential
boundary: The
target chemical should be classified as Aniline AND Aromatic
heterocyclic halide AND Aryl AND Aryl halide by Organic functional groups
Domain
logical expression index: "c"
Referential
boundary: The
target chemical should be classified as Aniline AND Aromatic
heterocyclic halide AND Aryl halide AND Overlapping groups by Organic
functional groups (nested)
Domain
logical expression index: "d"
Referential
boundary: The
target chemical should be classified as Aliphatic Nitrogen, one aromatic
attach [-N] AND Aromatic Carbon [C] AND Chlorine, aromatic attach [-Cl]
AND Chlorine, olefinic attach [-Cl] AND Olefinic carbon [=CH- or =C<] by
Organic functional groups (US EPA)
Domain
logical expression index: "e"
Referential
boundary: The
target chemical should be classified as Amine AND Aromatic compound AND
Aryl chloride AND Aryl halide AND Halogen derivative AND Primary amine
AND Primary aromatic amine by Organic functional groups, Norbert Haider
(checkmol)
Domain
logical expression index: "f"
Referential
boundary: The
target chemical should be classified as Weak binder, NH2 group by
Estrogen Receptor Binding
Domain
logical expression index: "g"
Parametric
boundary:The
target chemical should have a value of log Kow which is >= 1.62
Domain
logical expression index: "h"
Parametric
boundary:The
target chemical should have a value of log Kow which is <= 2.02
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 127 mg/kg bw/day
- Study duration:
- chronic
- Species:
- rat
- Quality of whole database:
- The data is K2 level as the data has been obtained from QSAR model considered by OECD.
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Toxicity to reproduction
WoE Summary of 108-42-9 for toxicity to reproduction
Based on the various studies available with Klimish rating 2 and 4 for the target as well as the read across substances for CAS: 108-42-9 based on the category approach of organic functional group along with similar mechanistic approach and having structural similarities defined by QSAR toolbox. This data is combined with the prediction done using the QSAR toolbox for the target chemical based on similar category approach, the results are summarized as follows
Sr. No |
End point |
Value |
Species |
Route |
Effects |
Remarks |
1 |
NOAEL
|
127 mg/kg bw/day (actual dose received) |
Rat |
Oral |
No clinical signs of toxicity were reported. |
Predicted data for target chemical (108-42-9) |
2 |
NOAEL
|
25 mg/kg bw |
Rat |
Oral |
No statistically significant or toxicologically relevant adverse effects on any of the maternal reproductive parameters studied were observed in the 25 mg/kg dose groups. |
Data from study report for RA CAS:95-76-1 |
LOAEL |
125 mg/kg bw |
The test article did, however, produce a slight (though not statistically, significant) increase in absorptions and consequently in post-implantation loss at 125 mg/kg. |
||||
3. |
NOAEL
|
10 mg/kg bw/day
|
Rat |
Oral |
No effects observed on clinical signs , mortality , body weight , food consumption as well as gross and histopathology. |
Data from study report for RA CAS:108-45-2 |
LOAEL
|
90 mg/kg bw/day |
|
|
Effects observed on the following parameters that were examined :Clinical signs, mortality, body weight, food consumption, reproductive performance, Gross and histopathology. |
Based on the studies summarized in the above table it can be observed that the endpoint low observed effect value (LOAEL) varies from 90 mg/kg bw/day to 125 mg/kg bw as well as no effect value (NOAEL) varies from 10 mg/kg bw/day to 127 mg/kg bw/day (actual dose received) based on the data from prediction as well as publication for target & read across substance. The effect observed on the above doses are-
· Produce a slight (though not statistically, significant) increase in absorptions and consequently in post-implantation loss.
· Effects observed on clinical signs, mortality, body weight, food consumption, reproductive performance, Gross and histopathology.
· No clinical signs of toxicity were reported.
· No statistically significant or toxicologically relevant adverse effects on any of the maternal reproductive parameters studied were observed in the 25 mg/kg dose groups.
· No effects observed on clinical signs , mortality , body weight , food consumption as well as gross and histopathology.
Thus based on the above results it can be concluded that the substance CAS: 108-42-9 is expected to show the similar toxicological effect based on the effects observed on the other category members. Since low effective dose value (LOAEL) is higher than 90 mg/kg bw/day thus based on this value it can be concluded that substance CAS: 108-42-9 is considered to be not toxic to reproduction below the dose level of 90 mg/kg bw/day. Also there are no known evidence of adverse effect on reproduction to human of CAS: 108-42-9.
Short description of key information:
From the various data available and adopting the weight of evidence approach, it has been concluded that 3-Chloroaniline is not likely to have reprotoxic effects within the dose levels mentioned in the respective end points.
Justification for selection of Effect on fertility via oral route:
The oral administration of 3-chloroaniline to male/female Sprague-Dawley rat ,at a dose level of 127 mg/kg bw/day (actual dose received).No clinical signs of toxicity were reported.
Thus the NOAEL for reproductive toxicity study was considered to be 127 mg/kg bw/day (actual dose received).
Effects on developmental toxicity
Description of key information
From the various data available and adopting the weight of evidence approach, it has been concluded that 3-chloroaniline is not likely to have teratogenic effects.
Link to relevant study records
- Endpoint:
- developmental toxicity
- Type of information:
- (Q)SAR
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Justification for type of information:
- QSAR prediction: migrated from IUCLID 5.6
- Principles of method if other than guideline:
- Prediction is done using QSAR Toolbox version 3.1
- GLP compliance:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on test animals or test system and environmental conditions:
- Sex : female
- Route of administration:
- oral: gavage
- Type of inhalation exposure (if applicable):
- not specified
- Vehicle:
- not specified
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- day 6 - 15 of gestation
- Frequency of treatment:
- daily
- Control animals:
- not specified
- Details on maternal toxic effects:
- Maternal toxic effects:no data
- Dose descriptor:
- other: not specified
- Based on:
- not specified
- Basis for effect level:
- other: not specified
- Remarks on result:
- other: not specified
- Abnormalities:
- not specified
- Localisation:
- not specified
- Description (incidence and severity):
- not specified
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:yes
Details on embryotoxic / teratogenic effects:
Fetal weight decreased - Dose descriptor:
- LOAEL
- Effect level:
- 130 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- not specified
- Basis for effect level:
- other: fetotoxicity
- Remarks on result:
- other: not specified
- Abnormalities:
- not specified
- Localisation:
- other: not specified
- Description (incidence and severity):
- not specified
- Developmental effects observed:
- not specified
- Treatment related:
- not specified
- Conclusions:
- The oral administration of 3-chloroaniline to female Sprague-Dawley rat by gavage,at a dose level of 130 mg/kg bw/day (actual dose received),resulted in a decreased fetal weight.Thus the LOAEL(lowest observed adverse effect level) for fetotoxicity study was considered to be 130 mg/kg bw/day (actual dose received),it is regarded that at concentrations lower than 130 mg/kg bw/day (actual dose received) there will be no fetotoxicity when administered orally.
- Executive summary:
The oral administration of 3-chloroaniline to female Sprague-Dawley rat by gavage,at a dose level of 130 mg/kg bw/day (actual dose received),resulted in a decreased fetal weight.Thus the LOAEL(lowest observed adverse effect level) for fetotoxicity study was considered to be 130 mg/kg bw/day (actual dose received),it is regarded that at concentrations lower than 130 mg/kg bw/day (actual dose received) there will be no fetotoxicity when administered orally.
Reference
The
prediction was based on dataset comprised from the following
descriptors: NOAEL,LOAEL,LOAEC
Estimation method: Takes average value from the 5 nearest neighbours
Domain logical expression:Result: In Domain
((("a"
or "b" or "c" or "d" or "e" )
and "f" )
and ("g"
and "h" )
)
Domain
logical expression index: "a"
Referential
boundary: The
target chemical should be classified as Anilines (Acute toxicity) by
US-EPA New Chemical Categories
Domain
logical expression index: "b"
Referential
boundary: The
target chemical should be classified as Aniline AND Aromatic
heterocyclic halide AND Aryl AND Aryl halide by Organic functional groups
Domain
logical expression index: "c"
Referential
boundary: The
target chemical should be classified as Aniline AND Aromatic
heterocyclic halide AND Aryl halide AND Overlapping groups by Organic
functional groups (nested)
Domain
logical expression index: "d"
Referential
boundary: The
target chemical should be classified as Aliphatic Nitrogen, one aromatic
attach [-N] AND Aromatic Carbon [C] AND Chlorine, aromatic attach [-Cl]
AND Chlorine, olefinic attach [-Cl] AND Olefinic carbon [=CH- or =C<] by
Organic functional groups (US EPA)
Domain
logical expression index: "e"
Referential
boundary: The
target chemical should be classified as Amine AND Aromatic compound AND
Aryl chloride AND Aryl halide AND Halogen derivative AND Primary amine
AND Primary aromatic amine by Organic functional groups, Norbert Haider
(checkmol)
Domain
logical expression index: "f"
Referential
boundary: The
target chemical should be classified as Weak binder, NH2 group by
Estrogen Receptor Binding
Domain
logical expression index: "g"
Parametric
boundary:The
target chemical should have a value of log Kow which is >= 0.705
Domain
logical expression index: "h"
Parametric
boundary:The
target chemical should have a value of log Kow which is <= 2.02
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LOAEL
- 130 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- The data is K2 level as the data has been obtained from QSAR model considered by OECD.
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
WoE Summary of 108-42-9 for developmental toxicity
Based on the various studies available with Klimish rating 2 and 4 for the target as well as the read across substances for CAS: 108-42-9 based on the category approach of organic functional group along with similar mechanistic approach and having structural similarities defined by QSAR toolbox. This data is combined with the prediction done using the QSAR toolbox for the target chemical based on similar category approach, the results are summarized as follows
Sr. No |
End point |
Value |
Species |
Route |
Effects |
Remarks |
1 |
LOAEL(fetotoxicity) |
130 mg/kg bw/day (actual dose received) |
Sprague-Dawley, rat |
Oral(gavage) |
Foetal weight decreased |
Predicted data for target chemical (108-42-9 ) |
2 |
End point not reported (Teratogenicity study) |
- |
Human |
No effects observed. |
Predicted data for target chemical (108-42-9 ) |
|
3 |
NOAEL (Maternal toxicity)
LOAEL (teratogenicity) |
25 mg/kg
125 mg/kg
|
Charles River CrI:CD BR, rat |
Oral(gavage) |
No statistically significant or toxicologically relevant adverse effects on any of the maternal reproductive or embryotoxicity parameters studied.
A significant delay in ossification of a few skeletal elements of the fetuses in this high-dose group was observed.
|
Data from study report for RA CAS : 95-76-1 |
4 |
TDLo - Lowest published toxic dose (developmental toxicity) |
375 mg/kg |
Rat |
intraperitoneal |
Fetal death observed. |
Data from publication for RA CAS : 108-45-2 |
5. |
LOAEL (maternal toxicity)
LOAEL (teratogenicity) |
90 mg/kg bw/day
90 mg/kg bw/day
|
Rat |
oral: gavage |
Effects observed on the following parameters that were examined :Clinical signs, mortality, body weight, food consumption ,reproductive performance, gross and histopathology. A smaller number of litters with living fetuses, lower placental weight, fewer living fetuses/litter, lower body weight of a living fetus, more total resorption,a higher number of dead fetuses, a higher percentage of dams with minor changed fetuses, a greater incidence of fetuses with minor malformations was observed. |
Data from study report for RA CAS : 108-45-2 |
Based on the studies summarized in the above table with various routes it can be observed that the low observed effect level (LOAEL) varies from 90 mg/kg bw/day to 130 mg/kg bw/day (actual dose received) and the lowest published toxic dose is 375 mg/kg based on the data from prediction as well as publication for target &read across substance. The effect observed on the above doses are-
· Fetal weight decreased.
· A significant delay in ossification of a few skeletal elements of the fetuses in this high-dose group was observed.
· Fetal death observed.
· A smaller number of litters with living fetuses, lower placental weight, fewer living foetuses /litter, lower body weight of a living fetus, more total resorption, a higher number of dead fetuses, a higher percentage of dams with minor changed fetuses, a greater incidence of fetuses with minor malformations was observed.
Thus based on the above results it can be concluded that substance CAS: 108-42-9 is expected to show the similar toxicological effect based on the effects observed on the other category members. Since low effective dose value (LOAEL) is higher than 90 mg/kg bw/day thus based on this value it can be concluded that substance CAS: 108-42-9 is considered to be not toxic to teratogenic effects below the dose level of 90 mg/kg bw/day. Also there are no known evidence of adverse effect on reproduction to human of CAS: 108-42-9.
Justification for selection of Effect on developmental toxicity: via oral route:
The oral administration of 3-chloroaniline to female Sprague-Dawley rat by gavage,at a dose level of 130 mg/kg bw/day (actual dose received),resulted in a decreased fetal weight.Thus the LOAEL(lowest observed adverse effect level) for fetotoxicity study was considered to be 130 mg/kg bw/day (actual dose received),it is regarded that at concentrations lower than 130 mg/kg bw/day (actual dose received) there will be no fetotoxicity when administered orally.
Justification for classification or non-classification
From the NOAEL and LOAEL values obtained for 3-Chloroaniline for toxicity to reproduction as well as developmental toxicity, it is considered that the chemical does not qualify for classification as a reproductive or developmental toxicant.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
